Viewing Study NCT03672292


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2026-02-18 @ 12:33 AM
Study NCT ID: NCT03672292
Status: TERMINATED
Last Update Posted: 2024-08-09
First Post: 2018-09-11
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis
Sponsor: Scynexis, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SCY-078-206
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators